Southwest Airlines Co. LUV
Southwest's board entrenched itself with a poison pill instead of fixing chronic underperformance; Elliott demands CEO Bob Jordan out, the board reconstituted, and an external-led turnaround.
Thesis
This follow-up letter, published one month after Elliott's June 10 thesis deck on Southwest, argues that the board has forfeited credibility by responding to legitimate activist pressure with entrenchment rather than accountability. Elliott cites the June 26 guidance cut — the eighth in eighteen months — alongside the July 3 poison pill capping Elliott at 12.5% and the July 8 appointment of a handpicked pro-management director as evidence that CEO Bob Jordan and the current 15-member board cannot reform themselves. Elliott marshals quoted support from top-10 active shareholders, Artisan Partners, and SWAPA pilot-union leadership to demonstrate overwhelming sentiment for change. The demands are explicit: retire the Executive Chairman role, add Elliott-identified independent airline veterans, announce an immediate CEO transition with external search, and launch a comprehensive business review under a new board committee.
SCQA
Southwest Airlines, once the industry's low-cost leader, has become a chronic laggard under CEO Bob Jordan, with eight guidance cuts in 18 months and a 15-member board that has not held management accountable.
Rather than address the performance crisis, on July 3 the Board adopted a poison pill capping Elliott at 12.5% and handpicked a pro-status-quo director — entrenchment moves that confirm the Board is protecting itself rather than shareholders.
Reconstitute the Board with independent airline veterans Elliott has identified, retire the Executive Chairman role, announce an immediate CEO transition with external search, and empower a new Business Review Committee to run a strategic reset.
Restore Southwest to industry-leading performance by pairing its franchise strengths with proven external airline operators, ending chronic guidance misses and the value destruction shareholders and employees have endured.
The three reasons
- 1
Southwest issued its eighth guidance cut in 18 months on June 26 — chronic underperformance
- 2
Board adopted poison pill and packed itself with a handpicked director — entrenchment, not accountability
- 3
Shareholders, Artisan Partners, and SWAPA pilots publicly demand wholesale leadership change
Primary demands
- Reconstitute the Board with independent former airline executives identified by Elliott
- Retire the Executive Chairman role and appoint an independent outside chair
- Announce immediate CEO transition and name an interim CEO trusted by investors
- Form a CEO search committee to recruit an external airline/transportation executive
- Launch a comprehensive business review under a new Board-level Business Review Committee
- Rescind the July 3 poison pill capping Elliott's stake at 12.5%
KPIs cited
Pattern membership
Composition what's on the 6 slides
Slide gallery ·
Notes
Six-page Elliott letter to Southwest's board, follow-up to June 10, 2024 thesis deck/presentation. Pure prose memo on Elliott letterhead — no charts, no slides, no valuation. Rhetorical strength comes from stacking shareholder and employee quotes ('The CEO is a headwind to a turnaround. Firing him is the tailwind.') plus an enumerated three-point demand list. Reacts to Board's July 3 poison pill (12.5% trigger) and handpicked 15th director, framed as admissions of failure. Poison pill cap of 12.5% implies Elliott's stake sat just below that, but no explicit ownership figure is disclosed in this document. Signed by John Pike (Partner) and Bobby Xu (Portfolio Manager) — team signature, not a firm-principal. Good specimen of the 'cascade of shareholder quotes' rhetorical pattern and of framing management defensive moves as admissions of failure.